Clinical Trial Update: Vaccine Study for Tick-Borne Encephalitis Virus (TBEV) [Phase 2]

View source ↗

Summary

Phase 2 trial of a tick-borne encephalitis vaccine candidate sponsored by NIAID was terminated, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tick-borne Encephalitis

Drugs mentioned

• NIAID Tick-borne encephalitis vaccine candidate

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Tick-Borne Encephalitis, Encephalitis, Tick-Borne | Phase 2 | Status: TERMINATED | Results posted: 2018-07-05